← 홈

CGT

1,235개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicstaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

Retinitis Pigmentosa; Retinitis · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 2

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

Refractory and Relapsed T Cell Lymphoma · T Lymphoblastic Leukemia/Lymphoma

#TLymphoblasticLeukemiaLymphoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 3상태 RECRUITING
CGTBiologicstaleJuno Therapeutics, a Subsidiary…Preclinical

JCAR015 (JCAR015)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
CGTBiologicstalePeter MacCallum Cancer Centre, …Phase 1

LeY CAR T cells (LeY CAR T cells)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 1

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Primary Central Nervous System (CNS) Lymphoma; Secondary Central Nervous System Lymphoma · Primary Central Nervous System (CNS) Lym

#PrimaryCentralNervousSystemCNSLy#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 3상태 RECRUITING
CGTBiologicstaleStephan Grupp MD PhDPhase 2

Murine CART19 (Murine CART19)

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL; Infants With Very High Risk KMT2A B-ALL · Pediatric and Young Adult Patientswith H

#PediatricandYoungAdultPatientswi#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 3상태 RECRUITING
CGTBiologicstaleNkarta, Inc.Phase 1

NKG2D CAR-NK (NKG2D CAR-NK)

AML · AML

#AML#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
CGTBiologicstaleAlaunos TherapeuticsPhase 2

Neoantigen specific TCR-T cell drug product (Neoantigen specific TCR-T cell drug product)

Gynecologic Cancer; Colorectal Cancer · Gynecologic Cancer

#GynecologicCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 DISCONTINUED
CGTBiologicstaleOrchard TherapeuticsPhase 2

OTL-200 Gene Therapy (OTL-200 Gene Therapy)

Lysosomal Storage Disease; Metachromatic Leukodystrophy · Lysosomal Storage Disease

#LysosomalStorageDisease#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTAAVBiologicstaleVegaVect, Inc.Phase 2

RS1 AAV Vector (RS1 AAV Vector)

Retinoschisis; X-Linked · Retinoschisis

#Retinoschisis#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 39.5%임상시험 3상태 ACTIVE
CGTBiologicstaleWuhan Sian Medical Technology C…Phase 1

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTBiologicstaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART19A (ThisCART19A)

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited · Allogeneic, CAR-T, Protein Sequestration

#AllogeneicCAR-TProteinSequestrat#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 3상태 RECRUITING
CGTBiologicstaleCellectis S.A.Phase 1

UCART123 (UCART123)

Acute Myeloid Leukaemia · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 DISCONTINUED
CGTBiologicstaleUniversity of Colorado, DenverPhase 1

UCD19 CAR T Cells (UCD19 CAR T Cells)

Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTAAVBiologicstaleMeiraGTx UK II LtdPhase 2

adeno-associated virus vector AAV- CNGA3 (adeno-associated virus vector AAV- CNGA3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
CGTBiologicstaleHrain Biotechnology Co., Ltd.Phase 1

anti-meso-CAR vector transduced T cells (anti-meso-CAR vector transduced T cells)

Malignant Mesothelioma; Pancreatic Cancer · Malignant Mesothelioma

#MalignantMesothelioma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
CGTBiologicstaleTmunity Therapeutics, a wholly …Phase 1

huCART-meso cells (huCART-meso cells)

Lung Adenocarcinoma; Ovarian Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0%임상시험 3상태 DISCONTINUED
CGTBiologicMedical College of WisconsinPhase 2

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

Non Hodgkin Lymphoma (NHL); Mantle Cell Lymphoma (MCL) · Non Hodgkin Lymphoma (NHL)

#NonHodgkinLymphomaNHL#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

21.15.GPC3-CAR T cells (21.15.GPC3-CAR T cells)

Atypical Teratoid Rhabdoid Tumor; Central Nervous System Rhabdoid Tumor · Hepatoblastoma

#Hepatoblastoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING

15 / 62 페이지

← 이전다음 →